| Date | Title | Description |
| 30.10.2024 | SciBase initiates sales collaboration in Italy | SciBase initiates sales collaboration in Italy
Wed, Oct 30, 2024 13:00 CET Report this content
SWEDEN, - October 30, 2024 - SciBase Holding AB ("SciBase") [STO: SCIB], a leading developer of augmented intelligence-based solutions ... |
| 21.10.2024 | SciBase continues US expansion and will attend Fall Clinical conference | SciBase continues US expansion and will attend Fall Clinical conference
Mon, Oct 21, 2024 08:00 CET Report this content
SWEDEN, - Oct 21, 2024 - SciBase Holding AB ("SciBase") [STO: SCIB], a leading developer of augmented intellig... |
| 15.10.2024 | SciBase and Cereno Scientific: Pioneering Innovations in Healthcare | In the ever-evolving landscape of healthcare, two companies stand out: SciBase Holding and Cereno Scientific. Both are on the cutting edge of medical technology and pharmaceuticals, each addressing critical health issues with innovative sol... |
| 14.10.2024 | Nomination Committee appointed for SciBase Holding’s Annual General Meeting in 2025 | Nomination Committee appointed for SciBase Holding’s Annual General Meeting in 2025
Mon, Oct 14, 2024 08:00 CET Report this content
The following people have been appointed as members of SciBase Holding’s nominating committee for the Annual... |
| 27.09.2024 | SciBase announces sale of Nevisense to NIH (US) | SciBase announces sale of Nevisense to NIH (US)
Fri, Sep 27, 2024 13:00 CET Report this content
SWEDEN, - Sept 27, 2024 - SciBase Holding AB ("SciBase") [STO: SCIB], pioneering prevention and prediction in dermatology disorders is... |
| 26.09.2024 | SciBase expands to new market in Pennsylvania and receives first order from large dermatology practice | SciBase expands to new market in Pennsylvania and receives first order from large dermatology practice
Thu, Sep 26, 2024 14:00 CET Report this content
SWEDEN, - Sept 26, 2024 - SciBase Holding AB ("SciBase") [STO: SCIB], pioneerin... |
| 02.09.2024 | New US Consensus Report supports Nevisense | New US Consensus Report supports Nevisense
Mon, Sep 02, 2024 08:45 CET Report this content
Consensus reached by top US clinicians assessing technologies for melanoma detection and management
The report concludes that the Nevisense AI-driven... |
| 21.08.2024 | Shifting Gears in Biotech: SciBase and AAX Biotech Make Strategic Moves | In the fast-paced world of biotechnology, change is the only constant. Companies must adapt, evolve, and sometimes pivot to stay relevant. Recently, two Swedish biotech firms, SciBase and AAX Biotech, made significant announcements that ref... |
| 21.08.2024 | SciBase changes Certified Adviser to Carnegie Investment Bank AB (publ). | SciBase changes Certified Adviser to Carnegie Investment Bank AB (publ).
Wed, Aug 21, 2024 09:00 CET Report this content
STOCKHOLM, SWEDEN, 21 August 2024 - SciBase Holding AB ("SciBase") [STO: SCIB], SciBase], a leading developer... |
| 21.08.2024 | Interim report | Interim report
Wed, Aug 21, 2024 08:00 CET Report this content
January 1 – June 30, 2024
The second quarter in figures Net sales were TSEK 6,641 (5,085), +31%. The loss after tax was TSEK 15,050 (11,352). The loss per share was SEK 0.08 (0.... |
| 28.06.2024 | SciBase partner with a large health care group in Los Angeles, Unified Health, and receives a first order | SciBase partner with a large health care group in Los Angeles, Unified Health, and receives a first order
Fri, Jun 28, 2024 11:30 CET Report this content
STOCKHOLM, SVERIGE, 28 June 2024 - SciBase Holding AB ("SciBase") [STO: SCIB... |
| 13.06.2024 | SciBase welcomes new chairman and thanks the former | SciBase welcomes new chairman and thanks the former
Thu, Jun 13, 2024 16:30 CET Report this content
STOCKHOLM, SVERIGE, 13 June 2024 - SciBase Holding AB ("SciBase") [STO: SCIB], SciBase, a leading developer of AI-based solutions ... |
| 13.06.2024 | SciBase strengthens the US organization with experienced leader in dermatology | SciBase strengthens the US organization with experienced leader in dermatology
Thu, Jun 13, 2024 13:00 CET Report this content
STOCKHOLM, SVERIGE, 13 June 2024 - SciBase Holding AB ("SciBase") [STO: SCIB], SciBase, a leading devel... |
| 31.05.2024 | Today is the first day of trading in the new shares and warrants of series TO 2 issued in connection with the completed capital raising | Today is the first day of trading in the new shares and warrants of series TO 2 issued in connection with the completed capital raising
Fri, May 31, 2024 07:45 CET Report this content
Today, 31 May 2024, trading in the new shares and warran... |
| 31.05.2024 | Interim report | Interim report
Fri, May 31, 2024 08:00 CET Report this content
January 1 –March 31, 2024
The first quarter in figures Net sales were TSEK 6,057 (5,149), +18%. The loss after tax was TSEK 10,861 (10,906). The loss per share was SEK 0.09 (0.1... |
| 30.05.2024 | SciBase receives first order in Austria | SciBase receives first order in Austria
Thu, May 30, 2024 08:00 CET Report this content
STOCKHOLM, SWEDEN, - May 30, 2024 - SciBase Holding AB ("SciBase") [STO: SCIB], a leading developer of artificial intelligence (AI)-based solu... |
| 29.05.2024 | SciBase Announces the launch of eBarrier Score, the First AI-Driven Skin Barrier Assessment tool for research and Cosmetic Testing | SciBase Announces the launch of eBarrier Score, the First AI-Driven Skin Barrier Assessment tool for research and Cosmetic Testing
Wed, May 29, 2024 08:00 CET Report this content
STOCKHOLM, SWEDEN, - May 29, 2024 - SciBase Holding AB ("... |
| 22.05.2024 | SciBase publishes the Annual report for 2023 | SciBase publishes the Annual report for 2023
Wed, May 22, 2024 09:00 CET Report this content
SciBase hereby announces that the Annual report for 2023 is available at the Company’s website www.scibase.com.
A pdf-version of the annual report ... |
| 22.05.2024 | New German study shows Nevisense significantly improves dermatologists clinical decisions | New German study shows Nevisense significantly improves dermatologists clinical decisions
Wed, May 22, 2024 13:30 CET Report this content
STOCKHOLM, SWEDEN, - May 22, 2024 - SciBase Holding AB ("SciBase") [STO: SCIB], a leading de... |
| 13.05.2024 | SciBase announces outcome in the directed issue of units | SciBase announces outcome in the directed issue of units
Mon, May 13, 2024 15:00 CET Report this content
On 5 April 2024 SciBase Holding AB (publ) ("SciBase" or the "Company") announced that the Company's board of direct... |
| 13.05.2024 | Notice to attend the annual general meeting in SciBase Holding AB (publ) | Notice to attend the annual general meeting in SciBase Holding AB (publ)
Mon, May 13, 2024 11:00 CET Report this content
The shareholders in SciBase Holding AB (publ), reg. no. 556773-4768 (the “Company”), are hereby given notice to attend ... |
| 13.05.2024 | Bulletin from the extraordinary general meeting in SciBase Holding AB (publ) | Bulletin from the extraordinary general meeting in SciBase Holding AB (publ)
Mon, May 13, 2024 10:00 CET Report this content
Today, an extraordinary general meeting has been held in SciBase Holding AB (publ) ("SciBase" or the &quo... |
| 10.05.2024 | SciBase announces outcome in rights issue of units | SciBase announces outcome in rights issue of units
Fri, May 10, 2024 13:00 CET Report this content
The Board of Directors in SciBase Holding AB (publ) ("SciBase" or the "Company") today announces the outcome in the right... |
| 02.05.2024 | SciBase supports clinicians during US Skin Cancer Awareness Month | SciBase supports clinicians during US Skin Cancer Awareness Month
Thu, May 02, 2024 08:00 CET Report this content
STOCKHOLM, SWEDEN, - May 02, 2024 - SciBase Holding AB ("SciBase") [STO: SCIB], a pioneer in skin cancer detection a... |
| 02.05.2024 | Last day of trading in unit rights in SciBase rights issue | Last day of trading in unit rights in SciBase rights issue
Thu, May 02, 2024 08:30 CET Report this content
Today, 2 May 2024, is the last day of trading in unit rights in SciBase Holding AB (publ) ("SciBase" or the "Company&q... |
| 24.04.2024 | SciBase Partners with Al Shirawi Healthcare solutions to Offer Nevisense in UAE | SciBase Partners with Al Shirawi Healthcare solutions to Offer Nevisense in UAE
Wed, Apr 24, 2024 08:00 CET Report this content
STOCKHOLM, SWEDEN, - April 24, 2024 - SciBase Holding AB ("SciBase") [STO: SCIB], a leading developer ... |
| 23.04.2024 | SciBase will present at the Redeye Medtech Event on April 24[th] | SciBase will present at the Redeye Medtech Event on April 24[th]
Tue, Apr 23, 2024 14:15 CET Report this content
STOCKHOLM, SWEDEN, - April 23, 2024 - SciBase Holding AB ("SciBase") [STO: SCIB], a leading developer of augmented in... |
| 23.04.2024 | Today is the first day of the subscription period in SciBase rights issue | Today is the first day of the subscription period in SciBase rights issue
Tue, Apr 23, 2024 08:00 CET Report this content
Today, 23 April 2024, the subscription period in SciBase Holding AB (publ) ("SciBase" or the "Company&q... |
| 19.04.2024 | SciBase publishes prospectus in connection with upcoming rights issue | SciBase publishes prospectus in connection with upcoming rights issue
Fri, Apr 19, 2024 14:15 CET Report this content
On 5 April 2024, SciBase Holding AB (publ) ("SciBase" or the "Company") announced that the Board of Di... |
| 08.04.2024 | Notice to extraordinary general meeting in Scibase Holding AB (publ) | Notice to extraordinary general meeting in Scibase Holding AB (publ)
Mon, Apr 08, 2024 08:30 CET Report this content
Shareholders of SciBase Holding AB (publ), reg. no. 556773-4768 (the "Company"), are hereby summoned to an extrao... |
| 05.04.2024 | SciBase resolves on a directed issued of approximately SEK 33 million and a rights issue of approximately SEK 15 million | SciBase resolves on a directed issued of approximately SEK 33 million and a rights issue of approximately SEK 15 million
Fri, Apr 05, 2024 14:20 CET Report this content
The Board of Directors SciBase Holding AB (publ) ("SciBase" o... |
| 28.02.2024 | SciBase Partners with Skinobs to Offer Nevisense on Global Cosmetic Testing Platform | SciBase Partners with Skinobs to Offer Nevisense on Global Cosmetic Testing Platform
Wed, Feb 28, 2024 08:00 CET Report this content
STOCKHOLM, SWEDEN, - February 28, 2024 - SciBase Holding AB ("SciBase") [STO: SCIB], a leading de... |
| 21.02.2024 | Year-end report | Year-end report
Wed, Feb 21, 2024 08:00 CET Report this content
January 1 – December 31, 2023
The fourth quarter in figures Net sales were TSEK 5,764 (4,962), +16%. The loss after tax was TSEK 20,541 (15,460). The loss per share was SEK 0.1... |
| 19.02.2024 | Keynote speakers presented Nevisense at the 2024 Winter Clinical Dermatology Conference in Miami | Keynote speakers presented Nevisense at the 2024 Winter Clinical Dermatology Conference in Miami
Mon, Feb 19, 2024 16:15 CET Report this content
STOCKHOLM, SWEDEN, - February 19, 2024 - SciBase Holding AB ("SciBase") [STO: SCIB], ... |
| 16.02.2024 | New study shows Nevisense evaluates skin barrier function with less sensitivity to lifestyle factors than TEWL | New study shows Nevisense evaluates skin barrier function with less sensitivity to lifestyle factors than TEWL
Fri, Feb 16, 2024 08:00 CET Report this content
STOCKHOLM, SWEDEN, - February 16, 2024 - SciBase Holding AB ("SciBase")... |
| 30.01.2024 | SciBase initiates collaboration with Inderes for commissioned research | SciBase initiates collaboration with Inderes for commissioned research
Tue, Jan 30, 2024 08:00 CET Report this content
STOCKHOLM, SWEDEN, - January 30, 2024 - SciBase Holding AB ("SciBase") [STO: SCIB], a pioneer in early detectio... |
| 25.01.2024 | Welcome to SciBase Capital Markets Day 2024 | Welcome to SciBase Capital Markets Day 2024
Thu, Jan 25, 2024 08:00 CET Report this content
STOCKHOLM, SWEDEN, - January 25, 2024 - SciBase Holding AB ("SciBase") [STO: SCIB], a pioneer in early detection and prevention in dermato... |
| 19.01.2024 | Reminder: Welcome to SciBase Capital Markets Day 2024 | Reminder: Welcome to SciBase Capital Markets Day 2024
Fri, Jan 19, 2024 11:00 CET Report this content
STOCKHOLM, SWEDEN, - January 19, 2024 - SciBase Holding AB ("SciBase") [STO: SCIB], a pioneer in early detection and prevention ... |
| 10.01.2024 | Letter from the CEO | Letter from the CEO
Wed, Jan 10, 2024 08:00 CET Report this content
In my initial 100 days as CEO, I have been creating a roadmap for SciBase's rapid transition into a robust commercial company. I am impressed by the work that has been done... |
| 09.01.2024 | Welcome to SciBase Capital Markets Day 2024 | Welcome to SciBase Capital Markets Day 2024
Tue, Jan 09, 2024 08:00 CET Report this content
STOCKHOLM, SWEDEN, - January 9, 2024 - SciBase Holding AB ("SciBase") [STO: SCIB], a leading developer of augmented intelligence-based sol... |
| 28.12.2023 | SciBase capital markets day 2024 - save the date | SciBase capital markets day 2024 - save the date
Thu, Dec 28, 2023 14:00 CET Report this content
STOCKHOLM, SWEDEN, - December 28, 2023 - SciBase Holding AB ("SciBase") [STO:SCIB], a leading developer of augmented intelligence-bas... |
| 04.12.2023 | Skin Cancer and Reconstructive Surgery Center of California Adopts AI-driven Nevisense for early skin cancer detection | Skin Cancer and Reconstructive Surgery Center of California Adopts AI-driven Nevisense for early skin cancer detection
Mon, Dec 04, 2023 08:00 CET Report this content
STOCKHOLM, SWEDEN, - December 04, 2023 - SciBase Holding AB ("SciBas... |
| 16.11.2023 | SciBase and Skin and Cancer Institute partner to advance AI-driven skin cancer detection in California | SciBase and Skin and Cancer Institute partner to advance AI-driven skin cancer detection in California
Thu, Nov 16, 2023 08:00 CET Report this content
STOCKHOLM, SWEDEN, - November 16, 2023 - SciBase Holding AB ("SciBase") [STO:SC... |
| 10.11.2023 | Interim report | Interim report
Fri, Nov 10, 2023 08:00 CET Report this content
January 1 – September 30, 2023
The third quarter in figures Net sales were TSEK 7,248 (4,941), +47%. The loss after tax was TSEK 12,786 (8,765). The loss per share was SEK 0.11 ... |
| 02.11.2023 | Nomination Committee appointed for SciBase Holding’s Annual General Meeting in 2024 | Nomination Committee appointed for SciBase Holding’s Annual General Meeting in 2024
Thu, Nov 02, 2023 08:00 CET Report this content
The following people have been appointed as members of SciBase Holding’s nominating committee for the Annual... |
| 29.09.2023 | Nevisense detects skin barrier damage from skin models in research | Nevisense detects skin barrier damage from skin models in research
Fri, Sep 29, 2023 08:00 CET Report this content
STOCKHOLM, SWEDEN, — September 29, 2023 – SciBase Holding AB (“SciBase”) [STO:SCIB], a leading developer of augmented intelli... |
| 28.09.2023 | Nevisense detects skin barrier dysfunction in children with Atopic Dermatitis | Nevisense detects skin barrier dysfunction in children with Atopic Dermatitis
Thu, Sep 28, 2023 08:00 CET Report this content
STOCKHOLM, SWEDEN, — September 28 2023 – SciBase Holding AB (“SciBase”) [STO:SCIB], a leading developer of augment... |
| 25.09.2023 | SciBase initiates pilot with Bare Dermatology to advance skin cancer detection in Texas | SciBase initiates pilot with Bare Dermatology to advance skin cancer detection in Texas
Mon, Sep 25, 2023 09:00 CET Report this content
STOCKHOLM, SWEDEN, – September 25, 2023 – SciBase Holding AB (“SciBase”) [STO:SCIB], a leading developer... |
| 04.09.2023 | SciBase strengthens US team with experienced Dermatology executive | SciBase strengthens US team with experienced Dermatology executive
Mon, Sep 04, 2023 08:00 CET Report this content
STOCKHOLM, SWEDEN, — September 4, 2023 – SciBase Holding AB (“SciBase”) [STO:SCIB], a leading developer of augmented intellig... |
| 29.08.2023 | SciBase appoints Pia Renaudin as Chief Executive Officer | SciBase appoints Pia Renaudin as Chief Executive Officer
Tue, Aug 29, 2023 16:30 CET Report this content
STOCKHOLM, SWEDEN, — August 29, 2023 – SciBase Holding AB (“SciBase”) [STO:SCIB], a leading developer of augmented intelligence-based s... |
| 18.08.2023 | Interim report | Interim report
Fri, Aug 18, 2023 08:00 CET Report this content
January 1 – June 30, 2023
The second quarter in figures Net sales were TSEK 5,085 (3,726), +36%. The loss after tax was TSEK 11,352 (9,212). The loss per share was SEK 0.16 (0.1... |
| 19.06.2023 | Letter from the Chairman of the Board | Letter from the Chairman of the Board
Mon, Jun 19, 2023 08:00 CET Report this content
Midsummer approaches and, as you know, Simon resigned a few weeks ago so we would like to give you a quick update on the recent progress at SciBase.
SciBa... |
| 17.05.2023 | Annual general meeting has been held in SciBase Holding AB (publ) | Annual general meeting has been held in SciBase Holding AB (publ)
Wed, May 17, 2023 17:30 CET Report this content
Today, the annual general meeting of 2023 was held in SciBase Holding AB (publ) (the “Company” or “SciBase”). Below follows a ... |
| 15.05.2023 | Clarification regarding announcement of senior management changes in SciBase | Clarification regarding announcement of senior management changes in SciBase
Mon, May 15, 2023 22:30 CET Report this content
STOCKHOLM, SWEDEN, — May 15, 2023 – SciBase Holding AB (“SciBase”) [STO:SCIB], a leading developer of augmented int... |
| 15.05.2023 | SciBase announces changes in senior management | SciBase announces changes in senior management
Mon, May 15, 2023 13:15 CET Report this content
STOCKHOLM, SWEDEN, — May 15, 2023 – SciBase Holding AB (“SciBase”) [STO:SCIB], a leading developer of augmented intelligence-based solutions for ... |
| 10.05.2023 | Correction of headline in published Interim report January - March 2023 | Correction of headline in published Interim report January - March 2023
Wed, May 10, 2023 09:17 CET Report this content
Headline of previously published Interim report January - March 2023 corrected including the headline in the attached pd... |
| 10.05.2023 | Interim report | Interim report
Wed, May 10, 2023 08:00 CET Report this content
January 1 – March 31, 2022
The first quarter in figures Net sales were TSEK 5,149 (4,260), +21%. The loss after tax was TSEK 10,906 (9,736). The loss per share was SEK 0.15 (0.1... |
| 21.04.2023 | SciBase publishes the Annual report for 2022 | SciBase publishes the Annual report for 2022
Fri, Apr 21, 2023 10:00 CET Report this content
SciBase hereby announces that the Annual report for 2022 is available at the Company’s website www.scibase.com.
A pdf-version of the annual report ... |
| 11.04.2023 | Notice to attend the annual general meeting in SciBase Holding AB (publ) | Notice to attend the annual general meeting in SciBase Holding AB (publ)
Tue, Apr 11, 2023 13:00 CET Report this content
The shareholders in SciBase Holding AB (publ), reg. no. 556773-4768 (the “Company”), are hereby given notice to attend ... |
| 04.04.2023 | SciBase receives increased US Medicare fee schedules for the Nevisense melanoma test | SciBase receives increased US Medicare fee schedules for the Nevisense melanoma test
Tue, Apr 04, 2023 08:00 CET Report this content
STOCKHOLM, SWEDEN, — April 4, 2023 – SciBase Holding AB (“SciBase”) [STO:SCIB], a leading developer of augm... |
| 29.03.2023 | SciBase and Schweiger Dermatology Group partner to advance skin cancer detection in select New Jersey locations | SciBase and Schweiger Dermatology Group partner to advance skin cancer detection in select New Jersey locations
Wed, Mar 29, 2023 08:00 CET Report this content
STOCKHOLM, SWEDEN, — March 29, 2023 – SciBase Holding AB (“SciBase”) [STO:SCIB],... |
| 23.03.2023 | SciBase announces outcome of rights issue of shares | SciBase announces outcome of rights issue of shares
Thu, Mar 23, 2023 20:00 CET Report this content
The board of directors of SciBase Holding AB (publ) ("SciBase" or the "Company") today announces the outcome of the full... |
| 02.03.2023 | SciBase publishes prospectus in connection with fully guaranteed rights issue | SciBase publishes prospectus in connection with fully guaranteed rights issue
Thu, Mar 02, 2023 10:45 CET Report this content
The board of directors of SciBase Holding AB (publ) (”Scibase” or the ”Company”) has prepared a prospectus in conn... |
| 13.02.2023 | SciBase resolves on a fully guaranteed rights issue of approximately SEK 79.6 million | SciBase resolves on a fully guaranteed rights issue of approximately SEK 79.6 million
Mon, Feb 13, 2023 08:45 CET Report this content
The board of directors of SciBase Holding AB (publ) ("SciBase" or the "Company") has t... |
| 13.02.2023 | Year-end report | Year-end report
Mon, Feb 13, 2023 08:00 CET Report this content
January 1 – December 31, 2022
The fourth quarter in figures Net sales were TSEK 4,962 (3,925), +26%. The loss after tax was TSEK 15,460 (13,852). The loss per share was SEK 0.2... |
| 22.12.2022 | Letter from the CEO | Letter from the CEO
Thu, Dec 22, 2022 08:00 CET Report this content
As the end of 2022 approaches, I’d like to take the opportunity to thank you all for your support for SciBase and review some of the highlights of an extremely eventful yea... |
| 15.12.2022 | Nevisense for skin barrier evaluation included in large Australian birth cohort study | Nevisense for skin barrier evaluation included in large Australian birth cohort study
Thu, Dec 15, 2022 08:00 CET Report this content
STOCKHOLM, SWEDEN, — December 15, 2022 – SciBase Holding AB (“SciBase”) [STO:SCIB], a leading developer of... |
| 15.12.2022 | Nevisense for skin barrier evaluation included in large Australian birth cohort study | STOCKHOLM, Dec. 15, 2022 /PRNewswire/ -- SciBase Holding AB ("SciBase") (STO: SCIB), a leading developer of augmented intelligence-based solutions for skin disorders announced today that SciBase has received an order for skin barr... |
| 10.11.2022 | Interim report | Interim report
Thu, Nov 10, 2022 08:00 CET Report this content
January 1 – September 30, 2022
The third quarter in figures Net sales amounted to TSEK 4,941 (2,982), +66%. The loss after tax amounted to TSEK 8,765 (8,622). The loss per share... |
| 08.11.2022 | SciBase CEO Simon Grant gives a comment regarding the collaboration with Johnson & Johnson Consumer Health | SciBase CEO Simon Grant gives a comment regarding the collaboration with Johnson & Johnson Consumer Health
Tue, Nov 08, 2022 09:00 CET Report this content
STOCKHOLM, SWEDEN - November 8, 2022 – SciBase Holding AB (“SciBase”) [STO:SCIB],... |
| 08.11.2022 | SciBase invitation to a webinar on November 10 at 11:00 CET | SciBase invitation to a webinar on November 10 at 11:00 CET
Tue, Nov 08, 2022 15:00 CET Report this content
STOCKHOLM, SWEDEN - November 8, 2022 – SciBase Holding AB (“SciBase”) [STO:SCIB], a leading developer of augmented intelligence-base... |
| 08.11.2022 | SciBase announces collaboration to detect skin barrier dysfunction in infants | STOCKHOLM, Nov. 8, 2022 /PRNewswire/ -- SciBase Holding AB ("SciBase") SCIB, a leading developer of augmented intelligence-based solutions for skin disorders, announced today that it has signed an agreement with Johnson & John... |
| 07.11.2022 | SciBase announces collaboration to detect skin barrier dysfunction in infants | SciBase announces collaboration to detect skin barrier dysfunction in infants
Mon, Nov 07, 2022 16:30 CET Report this content
November 7, 2022 – SciBase Holding AB (“SciBase”) [STO:SCIB], a leading developer of augmented intelligence-based ... |
| 27.10.2022 | New article discusses EIS as a potential clinical measure of skin barrier integrity | New article discusses EIS as a potential clinical measure of skin barrier integrity
Thu, Oct 27, 2022 08:00 CET Report this content
STOCKHOLM, SWEDEN, — October 27, 2022 – SciBase Holding AB (“SciBase”) [STO:SCIB], a leading developer of au... |
| 01.09.2022 | Nevisense detects skin barrier damage in mice caused by household detergents | Nevisense detects skin barrier damage in mice caused by household detergents
Thu, Sep 01, 2022 08:00 CET Report this content
STOCKHOLM, SWEDEN, — September 1, 2022 – SciBase Holding AB (“SciBase”) [STO:SCIB], a leading developer of augmente... |
| 18.08.2022 | Interim report | Interim report
Thu, Aug 18, 2022 08:00 CET Report this content
January 1 – June 30, 2022
The first quarter in figures Net sales amounted to TSEK 3,726 (2,258), +65%. The loss after tax amounted to TSEK 9,212 (11,151). The loss per share amo... |
| 09.08.2022 | FDA expert panel in line with SciBase position to keep stringent approval level for all new skin lesion analyzers | FDA expert panel in line with SciBase position to keep stringent approval level for all new skin lesion analyzers
Tue, Aug 09, 2022 08:00 CET Report this content
STOCKHOLM, SWEDEN, — August 9, 2022 – SciBase Holding AB (“SciBase”) [STO:SCIB... |
| 18.05.2022 | Annual general meeting has been held in SciBase Holding AB (publ) | Annual general meeting has been held in SciBase Holding AB (publ)
Wed, May 18, 2022 14:15 CET Report this content
Today, the annual general meeting of 2022 was held in SciBase Holding AB (publ) (the “Company” or “SciBase”). Below follows a ... |
| 16.05.2022 | US study shows that EIS and Nevisense significantly improves clinicians’ diagnostic accuracy | US study shows that EIS and Nevisense significantly improves clinicians’ diagnostic accuracy
Mon, May 16, 2022 08:00 CET Report this content
STOCKHOLM, SWEDEN, — May 16, 2022 – SciBase Holding AB (“SciBase”) [STO:SCIB], a leading developer ... |
| 12.05.2022 | Interim report | Interim report
Thu, May 12, 2022 08:00 CET Report this content
January 1 – March 31, 2022
The first quarter in figures Net sales amounted to TSEK 4,260 (2,562). The loss after tax amounted to TSEK 9,736 (8,153). The loss per share amounted ... |
| 10.05.2022 | SciBase to present at the Redeye Medtech & Diagnostics Seminar on May 11, 2022 | SciBase to present at the Redeye Medtech & Diagnostics Seminar on May 11, 2022
Tue, May 10, 2022 08:00 CET Report this content
SciBase a leading developer of augmented intelligence-based solutions for skin disorders, announced today tha... |
| 29.04.2022 | German study shows clinical benefit of Nevisense | German study shows clinical benefit of Nevisense
Fri, Apr 29, 2022 15:30 CET Report this content
STOCKHOLM, SWEDEN, — April 29, 2022 – SciBase Holding AB (“SciBase”) [STO:SCIB], a leading developer of augmented intelligence-based solutions ... |
| 22.04.2022 | SciBase publishes the Annual report for 2021 | SciBase publishes the Annual report for 2021
Fri, Apr 22, 2022 09:00 CET Report this content
SciBase hereby announces that the Annual report for 2021 is available at the Company’s website www.scibase.com.
A pdf-version of the annual report ... |
| 13.04.2022 | NOTICE TO ATTEND THE ANNUAL GENERAL MEETING IN SCIBASE HOLDING AB (PUBL) | NOTICE TO ATTEND THE ANNUAL GENERAL MEETING IN SCIBASE HOLDING AB (PUBL)
Wed, Apr 13, 2022 13:00 CET Report this content
The shareholders in SciBase Holding AB (publ), reg. no. 556773-4768 (the “Company”), are hereby given notice to attend ... |
| 30.03.2022 | SciBase further strengthens patent portfolio | SciBase further strengthens patent portfolio
Wed, Mar 30, 2022 08:00 CET Report this content
STOCKHOLM, SWEDEN, — March 30, 2022 – SciBase Holding AB (“SciBase”) [STO:SCIB], a leading developer of augmented intelligence-based solutions for ... |
| 23.03.2022 | SciBase receives largest electrode order from a single clinic valued at 60k€ | SciBase receives largest electrode order from a single clinic valued at 60k€
Wed, Mar 23, 2022 08:30 CET Report this content
STOCKHOLM, SWEDEN, — March 23, 2022 – SciBase Holding AB (“SciBase”) [STO:SCIB], a leading developer of augmented i... |
| 23.03.2022 | SciBase Barrier technology part of major immunodermatology project | SciBase Barrier technology part of major immunodermatology project
Wed, Mar 23, 2022 15:00 CET Report this content
STOCKHOLM, SWEDEN, — March 23, 2022 – SciBase Holding AB (“SciBase”) [STO:SCIB], a leading developer of augmented intelligenc... |
| 23.02.2022 | Year-end report | Year-end report
Wed, Feb 23, 2022 08:00 CET Report this content
January 1 – December 31, 2021
The fourth quarter in figures Net sales amounted to TSEK 3,925 (3,055). The loss after tax amounted to TSEK 13,852 (9,839). The loss per share amo... |
| 26.01.2022 | New Study published showing Nevisense impact on clinician confidence and accuracy | New Study published showing Nevisense impact on clinician confidence and accuracy Wed, Jan 26, 2022 08:00 CET
STOCKHOLM, SWEDEN, — January 26, 2022 – SciBase Holding AB (“SciBase”) [STO:SCIB], a leading developer of augmented intelligence-b... |
| 26.01.2022 | New Study published showing Nevisense impact on clinician confidence and accuracy | STOCKHOLM, SWEDEN, - January 26, 2022 - SciBase Holding AB ("SciBase") [STO:SCIB], a leading developer of augmented intelligence-based solutions for skin disorders, announced today that a new study supporting the use of Nevisense ... |
| 19.01.2022 | Letter from the CEO | Letter from the CEO Wed, Jan 19, 2022 09:00 CET
As we start 2022, I thought it a good opportunity to review some of the important events of 2021 and discuss our most recent progress.
The pandemic has during 2021 continued to play a role but... |
| 19.01.2022 | SciBase announces a change in the Management team and new head of Quality and Regulatory Affairs. | SciBase announces a change in the Management team and new head of Quality and Regulatory Affairs. Wed, Jan 19, 2022 08:00 CET
SciBase has appointed Alf Laurell as Director of Quality Assurance and Regulatory Affairs and Person for Regulator... |
| 19.01.2022 | Letter from the CEO | As we start 2022, I thought it a good opportunity to review some of the important events of 2021 and discuss our most recent progress.
The pandemic has during 2021 continued to play a role but even with the effects of Covid, it has still be... |
| 19.01.2022 | SciBase announces a change in the Management team and new head of Quality and Regulatory Affairs. | SciBase has appointed
Alf Laurell as Director of Quality Assurance and Regulatory Affairs and Person for Regulatory Compliance (PRRC) for SciBase. Alf joins SciBase from Elekta in Stockholm. The previous head of Quality and Regulatory and P... |
| 22.12.2021 | SciBase submits request for payment rate to NGS | SciBase submits request for payment rate to NGS Wed, Dec 22, 2021 08:00 CET
STOCKHOLM, SWEDEN, — December 22, 2021 – SciBase Holding AB (“SciBase”) [STO:SCIB], a leading developer of augmented intelligence-based solutions for skin disorders... |
| 16.12.2021 | Advanced Dermatology, P.C. adds ten new Nevisense installations to its extensive practice network. | Stockholm, Sweden and New York, US, - December 16, 2021 - SciBase Holding AB ("SciBase") [STO:SCIB], a leader of augmented intelligence-based solutions for skin disorders, announced today that it has received an order of ten addit... |
| 16.12.2021 | Advanced Dermatology, P.C. adds ten new Nevisense installations to its extensive practice network. | Advanced Dermatology, P.C. adds ten new Nevisense installations to its extensive practice network. Thu, Dec 16, 2021 08:00 CET
Stockholm, Sweden and New York, US, - December 16, 2021 - SciBase Holding AB ("SciBase") [STO:SCIB], a ... |
| 16.12.2021 | Advanced Dermatology, P.C. adds ten new Nevisense installations to its extensive practice network | STOCKHOLM and NEW YORK, Dec. 16, 2021 /PRNewswire/ -- SciBase Holding AB ("SciBase") (STO: SCIB), a leader of augmented intelligence-based solutions for skin disorders, announced today that it has received an order of ten addition... |
| 29.11.2021 | Article on consequences of MDR regulation within Dermatology published in JEADV | Article on consequences of MDR regulation within Dermatology published in JEADV Mon, Nov 29, 2021 08:00 CET
STOCKHOLM, SWEDEN, — November 29, 2021 – SciBase Holding AB ("SciBase") [STO:SCIB], a leading developer of augmented intel... |
| 11.11.2021 | Interim report | Interim report Thu, Nov 11, 2021 08:00 CET
January 1 – September 30, 2021
The third quarter in figures Net sales amounted to TSEK 2,982 (2,287). The loss after tax amounted to TSEK 8,622 (7,350). The loss per share amounted to SEK 0.13 (0.2... |
